Medications can be both a blessing and a curse. The drugs Sovaldi and now Harvoni promise to cure most hepatitis C patients for the first time. But the treatment is expensive. The US biopharmaceuticals company Gilead has been charging between 700 and 900 euros per pill.<br /><br />More Global 3000: http://www.dw.de/program/global-3000/s-11487-9798
